Highlights
• Zydus Cadila, part of Cadila Healthcare group in a BSE filing said it has received final approval from the United States Food and Drug Administration (USFDA) in order to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1,500 mg).
• Recently the Indian drug maker had received an USFDA approval to market doxorubicin hydrochloride liposome injection in th....
Tags : Zydus Cadila, Cadila Healthcare, Potassium Chloride, USFDA, FDA, ,
comments (0)